These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20728036)

  • 21. Massive transfusion and nonsurgical hemostatic agents.
    Perkins JG; Cap AP; Weiss BM; Reid TJ; Bolan CD
    Crit Care Med; 2008 Jul; 36(7 Suppl):S325-39. PubMed ID: 18594260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
    Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
    Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid.
    Menichetti A; Tritapepe L; Ruvolo G; Speziale G; Cogliati A; Di Giovanni C; Pacilli M; Criniti A
    J Cardiovasc Surg (Torino); 1996 Aug; 37(4):401-7. PubMed ID: 8698787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors.
    Lapecorella M; Napolitano M; Bernardi F; Pinotti M; Sbrighi PS; Marchetti G; Canella A; Caruso P; Orecchioni A; Mariani G
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):221-3. PubMed ID: 19144654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procoagulant therapeutics in liver disease: a critique and clinical rationale.
    Shah NL; Intagliata NM; Northup PG; Argo CK; Caldwell SH
    Nat Rev Gastroenterol Hepatol; 2014 Nov; 11(11):675-82. PubMed ID: 25023035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trauma, transfusions, and use of recombinant factor VIIa: A multicenter case registry report of 380 patients from the Western Trauma Association.
    Knudson MM; Cohen MJ; Reidy R; Jaeger S; Bacchetti P; Jin C; Wade CE; Holcomb JB
    J Am Coll Surg; 2011 Jan; 212(1):87-95. PubMed ID: 21115374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage.
    Grizelj R; Vuković J; Filipović-Grcić B; Sarić D; Luetić T
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):413-5. PubMed ID: 16788319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exsanguinating bleeding following tooth extraction in a 12-year-old girl: a rare case of acquired haemophilia A.
    Todo K; Ohmae T; Osamura T; Kiyosawa N; Sugimoto M; Shima M; Imamura T; Imashuku S
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):964-6. PubMed ID: 26397882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of recombinant activated factor VII (rFVIIa-NovoSeven) in the treatment of uncontrolled postsurgical hemorrhage in a patient with deep venous thrombosis and caval filter. A case report.
    Marson F; Farnia A; Callegher L; Casagrande L; Surdu M; Sarpellon M
    Minerva Anestesiol; 2006; 72(7-8):675-82. PubMed ID: 16865086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
    Tofil NM; Winkler MK; Watts RG; Noonan J
    Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tooth extraction and anticoagulants].
    Persac S; Boland FX; Lavis JF; Tardif A
    Rev Stomatol Chir Maxillofac; 2007 Jun; 108(3):189-92. PubMed ID: 17445849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypovolemic shock in a patients with cirrhosis secondary to hematoma of the psoas].
    Artigas MI; Miguelena PR
    Gastroenterol Hepatol; 2015 Nov; 38(9):566-7. PubMed ID: 25704635
    [No Abstract]   [Full Text] [Related]  

  • 33. Post-extraction bleeding--an aid to diagnosis? Case report.
    Songra AK; Darbar UR
    Aust Dent J; 1998 Aug; 43(4):242-3. PubMed ID: 9775470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant factor VIIa for the treatment of severe postoperative and traumatic hemorrhage.
    Khan AZ; Parry JM; Crowley WF; McAllen K; Davis AT; Bonnell BW; Hoogeboom JE
    Am J Surg; 2005 Mar; 189(3):331-4. PubMed ID: 15792762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention and treatment of major blood loss.
    Mannucci PM; Levi M
    N Engl J Med; 2007 May; 356(22):2301-11. PubMed ID: 17538089
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series.
    Alsayegh F; Fakeir A; Alhumood S; Abdumalek K; Matar H; Samaul I; Nampoory N; Kabalawi H; Mousa SA
    Clin Appl Thromb Hemost; 2009; 15(2):225-32. PubMed ID: 18160562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of a patient with Factor VII deficiency.
    Perhavec JC; Goldberg JS
    Oral Surg Oral Med Oral Pathol; 1980 Jul; 50(1):17-20. PubMed ID: 6930595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic methods to reduce perioperative bleeding.
    Levy JH
    Transfusion; 2008 Mar; 48(1 Suppl):31S-38S. PubMed ID: 18302580
    [No Abstract]   [Full Text] [Related]  

  • 39. [Recombinant activated factor VII in uncontrolled hemorrhage].
    Colomina MJ; Altisent C; Guerrero E; Godet C
    Med Clin (Barc); 2005 Feb; 124(4):156. PubMed ID: 15713248
    [No Abstract]   [Full Text] [Related]  

  • 40. Glanzmann's thrombasthenia: meeting the anticoagulation challenge.
    Binder A; Aledort L
    Haemophilia; 2015 Jul; 21(4):e322-3. PubMed ID: 25939445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.